Dr. Vinogradov's research primarily investigates how physical conditions and treatments affect performance and health outcomes in athletes, as well as in clinical settings for patients with serious health issues. He studies athletes, particularly elite soccer players, looking at factors like body composition and vitamin D levels that can influence injury risks and overall performance. Additionally, he explores cellular functions, particularly in relation to diabetes and cancer therapies, helping advance treatment options for conditions like metastatic kidney cancer and a rare skin cancer known as eccrine porocarcinoma.
Key findings
In elite soccer players, a 1% increase in body fat leads to a 61% higher risk of mild and minimal muscle injuries.
Mice lacking the TRPM7 protein produced 50% less glucagon, suggesting potential new insights for diabetes treatments.
Vitamin D supplementation improved normal levels in 60% of young soccer players after six weeks, versus only 4% in those not treated.
When starting 100 cm away from the line, young soccer players improved sprint times by 0.11 seconds, a 2.71% gain.
In cancer treatment, 1 out of 15 patients showed complete recovery after continuous interleukin-2 infusion for metastatic kidney cancer.
Frequently asked questions
Does Dr. Vinogradov study soccer injuries?
Yes, he researches factors affecting injury risk in elite soccer players, including body composition.
What treatments has Dr. Vinogradov researched for diabetes?
He studies the role of certain proteins in glucagon production, which could lead to new diabetes treatment approaches.
Is Dr. Vinogradov's work relevant for patients with kidney cancer?
Yes, he has researched treatment options for metastatic kidney cancer, showing promising outcomes with certain medications.
How does Dr. Vinogradov's research help young athletes?
His studies on performance and vitamin D deficiencies can help improve training practices and health in young athletes.
What is the significance of Dr. Vinogradov's cancer research?
His work provides insights into effective treatment strategies for rare cancers and conditions that have limited treatment options.
Publications in plain English
TRPM7 kinase regulates α-cell proliferation and glucagon production in mice.
2026
Molecular metabolism
Boulassel S, Schreier PCF, Beck A, Choi H, Melyshi AM +11 more
Plain English This study looked at how a protein called TRPM7 affects certain cells in the pancreas that produce glucagon, a hormone important for managing blood sugar levels. Researchers found that mice lacking TRPM7 released significantly less glucagon and had fewer α-cells, which was linked to problems with the mTOR signaling pathway; specifically, these mice produced around 50% less glucagon in response to stimuli than normal mice. This is important because understanding the role of TRPM7 could lead to new approaches for diabetes treatment by helping to maintain proper hormone levels.
Who this helps: This helps patients with diabetes and their doctors by potentially providing new treatment options.
Association Between Body Composition and Non-Contact Muscle Injury Risk in Elite Soccer Players: A Cox Proportional Hazards Model Analysis.
2026
Research quarterly for exercise and sport
Bezuglov E, Etemad O, Malyakin G, Vinogradov M, Talibov O +3 more
Plain English This study looked at how body composition affects the risk of non-contact muscle injuries in elite soccer players. Researchers followed 33 top male players over three seasons and found that players with a higher body fat percentage had a greater risk of getting minimal and mild injuries. Specifically, for every 1% increase in body fat, the risk of minimal and mild injuries increased by about 61%.
Who this helps: This information is useful for coaches and trainers aiming to reduce injury risks in soccer players.
Music as an ergogenic aid in team sports: a systematic review.
2025
Frontiers in sports and active living
Bezuglov E, Vakhidov T, Kapralova E, Malyakin G, Vinogradov M +2 more
Plain English This research looked at how listening to music affects athletic performance and endurance in team sports like football, volleyball, and basketball. Out of eight studies involving 140 athletes, most found that music improves various aspects of performance, such as sprinting and jumping, and helps athletes feel less tired while working hard. This is important because safe and easy methods like music can help athletes perform better and manage their energy during games.
Who this helps: This helps athletes, coaches, and sports teams looking to boost performance.
Elite football players achieve pre-injury running performance despite MRI lesions after return to play without increased risk of recurrence.
2025
Research in sports medicine (Print)
Bezuglov E, Izmailov S, Goncharov E, Grinchenko A, Etemad O +3 more
Plain English This study looked at whether MRI scans can be used to help football players safely return to playing after muscle injuries. Researchers found that, even though MRIs showed some signs of injury remained after players returned to the field, the athletes were able to run at the same speed and intensity as before their injury, and none had a higher risk of getting hurt again. This matters because it indicates that players can safely return to full performance without having to wait for all MRI signs to disappear.
Who this helps: This helps athletes and their doctors make more informed decisions about when to get back to playing after an injury.
Vitamin D Deficiency in Young Elite Soccer Players Residing Permanently in Regions above 55 Degrees North Latitude.
2025
Journal of bone metabolism
Bezuglov E, Vinogradov M, Anishchenko I, Vakhidov T, Usmanova E +2 more
Plain English This study looked at how vitamin D deficiency affects young soccer players living in areas above 55 degrees north latitude. The researchers gave 25 players a weekly dose of vitamin D for six weeks and found that 60% of them achieved normal vitamin D levels after treatment, compared to only 4% in the control group who did not receive the supplement. This is important because it shows that a simple weekly vitamin D supplement can significantly improve health outcomes for young athletes in regions where sunlight is limited.
Who this helps: Young soccer players in northern regions.
The influence of conditioning baths on the structure and properties of fibers spun from cellulose with low alpha content.
2025
Carbohydrate polymers
Makarov I, Vinogradov M, Palchikova E, Kulanchikov Y, Levin I +6 more
Plain English This study looked at how different conditioning baths affect the properties of cellulose fibers made from recycled materials. Researchers found that when fibers were treated with alcohol instead of water, their crystallinity increased, making them stronger and less stretchy, with relative elongation dropping to between 3% and 6%. This is important because it shows that using the right conditioning method can improve the performance of sustainable fibers, making them more viable for various uses.
Who this helps: This benefits manufacturers of sustainable textiles and clothing.
Comparative Analysis of Speed-Power Performance and Sport-Specific Skills Among Elite Youth Soccer Players with Different Start Procedures.
2025
Sports (Basel, Switzerland)
Bezuglov E, Emanov A, Vakhidov T, Kapralova E, Malyakin G +4 more
Plain English This study looked at how starting distance affects the speed and agility of elite young soccer players. Researchers found that starting 100 cm away from the starting line significantly improved sprint times and change-of-direction performance compared to starting 30 cm away. For example, sprinting 30 meters was faster by about 0.11 seconds, which is a 2.71% improvement. These findings are important because they can help coaches design better training programs that maximize player performance on the field.
Who this helps: This helps young soccer players improve their skills and coaches enhance training methods.
Development of Cellulose Microfibers from Mixed Solutions of PAN-Cellulose in N-Methylmorpholine-N-Oxide.
2024
Polymers
Makarov I, Vinogradov M, Golubev Y, Palchikova E, Kulanchikov Y +1 more
Plain English This study focused on creating cellulose microfibers using a special solution that combines PAN (a type of plastic) with cellulose. Researchers found that when the cellulose content was up to 40%, unique fibril structures formed, and the stiffness of the cellulose microfibers was notably high, measured at more than 30 GPa. This development is important because stronger microfibers can improve the quality and durability of materials used in various applications, such as textiles and composites.
Who this helps: This benefits manufacturers and industries that rely on strong, durable materials.
Gender Differences and Performance Changes in Sprinting and Long Jump Among Young Athletes.
2024
Sports (Basel, Switzerland)
Bezuglov E, Achkasov E, Vakhidov T, Malyakin G, Kapralova E +4 more
Plain English This study looked at how sprinting and long jump performances vary between boys and girls aged 10 to 15 in competitive athletics. Researchers found that boys started outperforming girls in both events by ages 11 and 12, with boys showing significant improvements in long jump between ages 12 and 13, while girls improved significantly in the same event between ages 12 and 13 as well. Understanding these differences is important for creating fair competition divisions that take into account the physical development of young athletes.
Who this helps: This benefits coaches, sports organizations, and young athletes.
The Thermal Behavior of Lyocell Fibers Containing Bis(trimethylsilyl)acetylene.
2021
Polymers
Makarov I, Vinogradov M, Mironova M, Shandryuk G, Golubev Y +1 more
Plain English This study looked at how adding a special chemical (bis(trimethylsilyl)acetylene) to cellulose fibers affects their properties when heated. Researchers found that this addition increased the amount of carbon obtained after burning off the original materials, improving carbon yield from these fibers. For the first time, they measured how much these fibers expand and contract with temperature changes, which is important for understanding how to use them in various applications.
Who this helps: This research benefits materials scientists and manufacturers looking to create stronger, more efficient carbon fibers for use in industries like aerospace and automotive.
Metastatic Porocarcinoma Effectively Managed by Pembrolizumab.
2021
Cureus
Singh A, Nguyen L, Everest S, Vinogradov M
Plain English This study focused on a rare skin cancer called eccrine porocarcinoma, which affects sweat glands. Researchers treated a 79-year-old man whose cancer came back multiple times and spread to other areas. After using an immunotherapy drug called pembrolizumab, the patient achieved remission, showing it can be an effective treatment option for this type of cancer.
Who this helps: This helps patients with eccrine porocarcinoma and doctors treating this rare cancer.
A Role of Coagulant in Structure Formation of Fibers and Films Spun from Cellulose Solutions.
2020
Materials (Basel, Switzerland)
Kulichikhin V, Makarov I, Mironova M, Golova L, Vinogradov M +3 more
Plain English This study explored how changing the liquid used to solidify cellulose fibers from a water-based solution to an alcohol-based one affects the fibers' structure and properties. Researchers found that using alcohol leads to different hydrogen bond formations and results in cellulose with a better-defined structure, making the fibers potentially more useful for applications like textiles and packaging. Specifically, when cellulose is treated with alcohol, it results in a "glassy" solid, while water produces a more mixed structure.
Who this helps: This benefits manufacturers and developers looking for improved materials for textiles, packaging, and other applications.
Sulfhydryl-specific PEGylation of phosphotriesterase cysteine mutants for organophosphate detoxification.
2015
Protein engineering, design & selection : PEDS
Daffu GK, Lopez P, Katz F, Vinogradov M, Zhan CG +2 more
Plain English The researchers studied a protein called phosphotriesterase (PTE), which can help detoxify harmful substances like pesticides. They created engineered versions of this protein with specific changes that made it more effective at binding to larger molecules, improving its ability to work in the body: one variant, called E116C, was particularly good at this, maintaining nearly the same efficiency as the original protein when detoxifying a toxic pesticide. This matters because enhancing the effectiveness and longevity of PTE could lead to better treatments for organophosphate poisoning.
Who this helps: This benefits patients who are exposed to organophosphate pesticides, potentially leading to quicker and more effective treatments.
Activity of continuous infusion plus pulse interleukin-2 with famotidine in patients with metastatic kidney cancer or melanoma previously treated with interleukin-2.
2006
Cancer biotherapy & radiopharmaceuticals
Quan WD, Walker PR, Quan FM, Ramirez M, Elsamaloty HM +3 more
Plain English This study looked at a new treatment approach for patients with metastatic kidney cancer or melanoma who did not respond to previous interleukin-2 (IL-2) therapy. Researchers treated 11 patients using a combination of famotidine and continuous IL-2, resulting in partial responses in 5 patients, with two kidney cancer patients achieving complete response after surgery, and a median survival of 12 months. This matters because it provides a potential new option for patients who have run out of effective treatments.
Who this helps: Patients with metastatic kidney cancer or melanoma.
Continuous infusion interleukin-2 and famotidine in metastatic kidney cancer.
2006
Cancer biotherapy & radiopharmaceuticals
Quan WD, Vinogradov M, Quan FM, Khan N, Liles DK +1 more
Plain English This study looked at how continuous infusion of a treatment called interleukin-2 (IL-2), combined with the drug famotidine, affects patients with advanced kidney cancer. Out of 15 patients treated, 1 patient experienced a complete recovery and 6 had partial improvements, leading to a total response rate of 47%. On average, patients lived for 20 months after starting treatment, and some are still alive after more than 3 years.
Who this helps: This benefits patients with metastatic kidney cancer and their doctors by providing a potential treatment option.
Administration of high-dose continuous infusion interleukin-2 to patients age 70 or over.
2005
Cancer biotherapy & radiopharmaceuticals
Quan W, Ramirez M, Taylor C, Quan F, Vinogradov M +1 more
Plain English This study looked at how older patients (70 and up) with certain types of cancer respond to high-dose continuous infusion interleukin-2 (IL-2) therapy, which can have serious side effects. Researchers treated 15 patients who were generally healthy for their age, and found that 60% showed some response to the treatment (1 complete and 8 partial responses), with no treatment-related deaths among them. This matters because it shows that older patients can potentially tolerate this treatment safely and benefit from it, despite concerns about its risks.
Who this helps: This helps cancer patients aged 70 and older.
High-dose continuous infusion plus pulse interleukin-2 and famotidine in metastatic kidney cancer.
2005
Cancer biotherapy & radiopharmaceuticals
Quan W, Ramirez M, Taylor C, Vinogradov M, Quan F +1 more
Plain English This study looked at a new treatment for advanced kidney cancer using high doses of a drug called interleukin-2 (IL-2) along with famotidine, a medication commonly used to treat heartburn. Out of six patients, two showed improvement in their condition, leading to a response rate of 33%, and none of the patients experienced severe side effects or required hospitalization. This research is important because it suggests a potentially effective treatment option for metastatic kidney cancer, offering hope for better outcomes for patients.
Who this helps: This helps patients with advanced kidney cancer.
Correlation between development of pulmonary edema and response of pulmonary metastases of metastatic melanoma and kidney cancer to high-dose continuous-infusion interleukin-2.
2005
Cancer biotherapy & radiopharmaceuticals
Quan WD, Khan N, Ramirez M, Taylor WC, Quan F +2 more
Plain English This study looked at how the side effect of pulmonary edema (fluid in the lungs) relates to the effectiveness of a treatment called high-dose interleukin-2 (IL-2) in patients with lung metastases from melanoma and kidney cancer. Among 18 patients, those who experienced pulmonary edema during treatment were more likely to respond positively to the therapy; specifically, 8 patients showed treatment responses, and 6 of them had pulmonary edema. The findings suggest that monitoring for pulmonary edema could be important in predicting which patients may respond better to IL-2 treatment.
Who this helps: This information is valuable for doctors treating melanoma and kidney cancer patients using IL-2 therapy.
Monitoring the acetohydroxy acid synthase reaction and related carboligations by circular dichroism spectroscopy.
2005
Analytical biochemistry
Vinogradov M, Kaplun A, Vyazmensky M, Engel S, Golbik R +6 more
Plain English This study focused on a specific enzyme called acetohydroxy acid synthase (AHAS), which helps produce important compounds used in various industries. Researchers found that a technique called circular dichroism spectroscopy is better for monitoring AHAS activity because it provides clear results without interference, making it easier to perform and more accurate compared to existing methods. The new method also helps identify another enzyme's products, confirming that it produces a specific type of compound.
Who this helps: This benefits researchers and scientists working on enzyme activity and those in fields like biotechnology and pharmaceuticals.
Cloning and characterization of acetohydroxyacid synthase from Bacillus stearothermophilus.
2004
Journal of bacteriology
Porat I, Vinogradov M, Vyazmensky M, Lu CD, Chipman DM +2 more
Plain English This study focused on understanding a specific enzyme called acetohydroxyacid synthase (AHAS) from a heat-loving bacterium called Bacillus stearothermophilus. The researchers sequenced five genes related to this enzyme and found that AHAS from this bacterium is similar to a version found in E. coli, showing that they share important features. This is significant because it helps scientists understand how this enzyme functions and its evolutionary relationship with similar enzymes in other bacteria, which could have implications for developing better industrial processes and antibiotics.
Who this helps: This information benefits researchers and developers working on antibiotics and industrial enzymes.
Role of a conserved arginine in the mechanism of acetohydroxyacid synthase: catalysis of condensation with a specific ketoacid substrate.
2004
The Journal of biological chemistry
Engel S, Vyazmensky M, Vinogradov M, Berkovich D, Bar-Ilan A +4 more
Plain English This study looked at an important enzyme called acetohydroxyacid synthase (AHAS), focusing on a specific part of its structure known as arginine. Researchers found that this arginine is essential for the enzyme to function quickly and accurately when combining two molecules to produce important compounds, like acetolactate. In experiments, altering this arginine slowed down the reaction significantly, indicating its critical role. Understanding this mechanism can help scientists redesign the enzyme to create new and useful biochemical reactions.
Who this helps: This research benefits biochemists and biotechnology developers looking to create more efficient enzymes for various applications.
Repeated cycles with 72-hour continuous infusion interleukin-2 in kidney cancer and melanoma.
2004
Cancer biotherapy & radiopharmaceuticals
Quan W, Brick W, Vinogradov M, Taylor WC, Khan N +1 more
Plain English This study examined the effects of a continuous infusion of interleukin-2 over 72 hours in patients with kidney cancer and melanoma. Researchers treated 14 patients, resulting in a 67% response rate in kidney cancer and a 25% response rate in melanoma, without any treatment-related deaths or ICU admissions. This is important because it shows that this treatment can be safely administered more frequently, potentially improving outcomes for patients with these types of cancer.
Who this helps: Patients with kidney cancer and melanoma.
High-dose continuous infusion plus pulse interleukin-2 and famotidine in melanoma.
2004
Cancer biotherapy & radiopharmaceuticals
Quan W, Ramirez M, Taylor WC, Vinogradov M, Khan N +1 more
Plain English This study examined a treatment for melanoma using high doses of interleukin-2 (IL-2) combined with the drug famotidine. Out of 14 patients, 9 showed improvement, leading to a 64% response rate. Most patients experienced side effects like fever and nausea, but the treatment appears effective, as some patients had promising signs of cancer cell response.
Who this helps: This benefits melanoma patients looking for effective treatment options.
The N-terminal domain of the regulatory subunit is sufficient for complete activation of acetohydroxyacid synthase III from Escherichia coli.
2003
Journal of molecular biology
Mendel S, Vinogradov M, Vyazmensky M, Chipman DM, Barak Z
Plain English This study focused on a specific part of a protein called the regulatory subunit of acetohydroxyacid synthase, which is important for the function of an enzyme in bacteria. The researchers found that a section at the beginning of this protein (around 80 amino acids long) is enough to activate the enzyme and help it work better, doubling its efficiency compared to the standard version. However, another part of the protein is needed to respond to the feedback regulator valine, showing that both sections play different, critical roles in how the enzyme functions.
Who this helps: Patients who rely on bacteria for certain metabolic functions may benefit from this research, as it can lead to better understanding and manipulation of bacterial enzymes.
Eduard Bezuglov Georgiy Malyakin Nawazish Khan Maria Ramirez Timur Vakhidov Elizaveta Kapralova Igor Makarov Maria Vyazmensky Ze'ev Barak David M Chipman
Physician data sourced from the
NPPES NPI Registry
.
Publication data from
PubMed
.
Plain-English summaries generated by AI.
Not medical advice.